Lipid but not glycaemic parameters predict total mortality from type 2 diabetes mellitus in Canterbury, New Zealand

Diabetic Medicine

Volumn 15, Issue 5, 1998, Pages 386-392

  Florkowski, C M ^a   Scott, R S ^a   Moir, C L ^a   Graham, P J ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Mortality; Type 2 diabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPID;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RISK ASSESSMENT;

ACCIDENTS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; CEREBROVASCULAR DISORDERS; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE; LIPIDS; MALE; MIDDLE AGED; NEOPLASMS; NEW ZEALAND; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEX FACTORS; SMOKING; SURVIVAL ANALYSIS;

EID: 0031956242     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199805)15:5<386::AID-DIA587>3.0.CO;2-D     Document Type: Article

References (37)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D for The Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434-444.
2. Finch C, Zimmet P. Mortality from diabetes. In: Alberti KGMM, Krall LP, eds. The Diabetes Annual/4. Amsterdam: Elsevier 1988: 1-16.
3. Knuiman MW, Welborn TA, Whittall DE. An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model. Am J Epidemiology 1992; 135: 638-646.
4. Sasaki A, Uehara M, Horiuchi N, Hasagawa K. A long-term follow-up study of Japanese diabetic patients: mortality and causes of death. Diabetologia 1983; 25: 309-312.
5. Barrett-Connor E, Wingard DL. Sex differential in ischaemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol 1983; 118: 489-496.
6. Zimmet PZ, Finch CF, Schooneveldt MG, King HO, Thoma K. Mortality from diabetes in Nauru: results of 4-yr follow-up. Diabetes Care 1988; 11: 305-310.
7. Wong JSK, Pearson DWM, Murchison LE, Williams MJ, Narayan V. Mortality in diabetes mellitus: experience of a geographically defined population. Diabetic Med 1991; 8: 135-139.
8. Head J, Fuller JH. International variations in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 1990; 33: 477-481.
9. Panzram G. Mortality and survival in type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1987; 80: 123-131.
10. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 1988; 128: 389-401.
11. van der Zwaag R, Runyan JW, Davidson JK, Delcher HK, Mainzer I, Baggett HW. A cohort study of mortality in two clinic populations of patients with diabetes mellitus. Diabetes Care 1983; 6: 341-346.
12. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Type 2 diabetes and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-907.
13. Laakso M. Glycaemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus: the Finnish Studies. Ann Intern Med 1996; 124: 127-130.
14. Laakso M, Lehto S, Pentilla I, Pyorala K. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 1993; 88: 1421-1430.
15. Welborn TA, Knuiman M, McCann V, Stanton K, Constable IJ. Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables. Diabetologia 1994; 27: 568-573.
16. Scragg R. Secular trends in mortality from diabetes mellitus in New Zealand, 1966-1985. In: Contemporary Health Issues. Wellington: National Health Statistics Centre 1989: 23-27.
17. Hay DR. Recent statistical information on cardiovascular disease in New Zealand. In: Heart Facts. National Heart Foundation of New Zealand Technical Report Series 1996: 1-16.
18. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
19. Haffner SM, Stern M, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the click for coronary heart disease start ticking before the onset of clinical diabetes? J Am Med Assoc 1990; 263: 2893-2898.
20. 1c with basal insulin supplement, sulfonylureas, or biguanide therapy in maturity-onset diabetes. Diabetes 1985; 34: 793-798.
21. Stout RW. Insulin and atheroma: 20 year perspective. Diabetes Care 1990; 13: 631-654.
22. New Zealand Society for the Study of Diabetes. Core components for a diabetes service. NZ Med J 1996; 108: 434-435.
23. Statistics New Zealand. New Zealand Life Tables 1990-1992. Wellington: Statistics New Zealand, 1996.
24. Rothman K. Modern Epidemiology. Boston: Little Brown & Co., 1986.
25. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman and Hall, 1984.
26. Krolewski AS, Czyzyk A, Janeczko D, Kopczynski J. Mortality from cardiovascular diseases among diabetics. Diabetologia 1997; 13: 345-350.
27. Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien P-J. Hyperinsulinaemia as an independent risk factor for ischaemic heart disease. N Engl J Med 1996; 334: 952-957.
28. Abraira C, Johnson N, Colwell J, the VA CSDM Group. VA cooperative study on glycaemic control and complications in type II diabetes (VA CSDM): results of the completed feasibility trial (Abstract). Diabetes 1994; 43 (suppl): 59A.
29. Standl E, Janka HU. High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. Horm Metab Res Suppl 1985; 15: 46-51.
30. University Group Diabetes Program. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult onset diabetes. II Mortality Results. Diabetes 1970; 19 (suppl 2): 785-830.
31. Filo C, Miller JP, Williamson JR. The crux of the university's group diabetes programme. Spurious results and inappropriate data analysis. Diabetologia 1980; 18: 179-185.
32. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycaemic control predict mortality in Type 2 Diabetes. Diabetes 1995; 44: 1303-1309.
33. Chan JC, Cheung CK, Cheung MY, Swaminathan R, Critchley JA, Cockram CS. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with Type 2 Diabetes. Diabetes Care 1995; 18: 1013-1016.
34. MacLeod JM, Lutale J, Marshall SM. Albumin excretion and vascular deaths in NIDDM. Diabetologia 1995; 38: 610-616.
35. Wang SL, Head J, Stevens L, Fuller JH. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The World Health Organization Multinational Study of Vascular Disease in Diabetes. Diabetes Care 1996; 19: 305-312.
36. Beaven DW, Scott RS. The organisation of diabetes care. In: The Diabetes Annual/2. Amsterdam: Elsevier 1986: 284-287.
37. Lever M, May PC, Andre C. Automated fluorimetric determination of furfurals. Analytical Biochemistry 1985; 144: 6-14.